From the Mayo Clinic to Harvard, sources don’t always get the facts right about preeclampsia. Reached by ProPublica, some are making needed corrections

Quick Read

He wants to give it away for free. A Harvard scientist thinks he’s reached a new milestone: a genetic test that help identify people who are at high risk of heart attacks. Can he convince doctors to use it?

Quick Read

Dependence is a special type of drug-related harm. It’s an adaptive phenomenon resulting from exposure to a centrally-active drug and defined by the development of withdrawal symptoms when the drug is removed or the dose lowered too quickly

Quick Read

Microbiome testing companies have become a thing, offering consumers a chance to see a snapshot of the billions of microbes that reside in their bodies. Some promise even more from a swab: personalized advice on how to improve your health

Quick Read

Julian Savulescu presents hypothetical cases to explore whether safe and effective gene therapy ought to be compulsory

Quick Read

People with multiple sclerosis sometimes become desperate and will travel to other countries for experimental stem cell treatments. That’s not always a good idea

Quick Read

Addyi Rises Again

July 11, 2018

Addyi, a drug that made a splash when it was approved in the summer of 2015 as the first “female Viagra,” is back. Its rise, fall, and rise again is an example of shrewd pharmaceutical marketing and the potential dangers it can have on patients

Quick Read

In a letter to the Baltimore Sun, a group of geneticists, genetic counselors, and ethicists, including our Debra Mathews, supports efforts to reunite immigrant families as quickly as possible, while raising serious concerns about the use of DNA testing as a means of achieving this goal

Quick Read